Literature DB >> 34546217

Multi-omic Analysis of Non-human Primate Heart after Partial-body Radiation with Minimal Bone Marrow Sparing.

Stephanie Zalesak-Kravec1, Weiliang Huang1, Pengcheng Wang1, Jianshi Yu1, Tian Liu1, Amy E Defnet1, Alexander R Moise2, Ann M Farese3, Thomas J MacVittie3, Maureen A Kane1.   

Abstract

ABSTRACT: High-dose radiation exposure results in hematopoietic and gastrointestinal acute radiation syndromes followed by delayed effects of acute radiation exposure, which encompasses multiple organs, including heart, kidney, and lung. Here we sought to further characterize the natural history of radiation-induced heart injury via determination of differential protein and metabolite expression in the heart. We quantitatively profiled the proteome and metabolome of left and right ventricle from non-human primates following 12 Gy partial body irradiation with 2.5% bone marrow sparing over a time period of 3 wk. Global proteome profiling identified more than 2,200 unique proteins, with 220 and 286 in the left and right ventricles, respectively, showing significant responses across at least three time points compared to baseline levels. High-throughput targeted metabolomics analyzed a total of 229 metabolites and metabolite combinations, with 18 and 22 in the left and right ventricles, respectively, showing significant responses compared to baseline levels. Bioinformatic analysis performed on metabolomic and proteomic data revealed pathways related to inflammation, energy metabolism, and myocardial remodeling were dysregulated. Additionally, we observed dysregulation of the retinoid homeostasis pathway, including significant post-radiation decreases in retinoic acid, an active metabolite of vitamin A. Significant differences between left and right ventricles in the pathology of radiation-induced injury were identified. This multi-omic study characterizes the natural history and molecular mechanisms of radiation-induced heart injury in NHP exposed to PBI with minimal bone marrow sparing.
Copyright © 2021 Health Physics Society.

Entities:  

Mesh:

Year:  2021        PMID: 34546217      PMCID: PMC8554778          DOI: 10.1097/HP.0000000000001478

Source DB:  PubMed          Journal:  Health Phys        ISSN: 0017-9078            Impact factor:   2.922


  129 in total

Review 1.  From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease.

Authors:  Alan H Gradman; Fadi Alfayoumi
Journal:  Prog Cardiovasc Dis       Date:  2006 Mar-Apr       Impact factor: 8.194

2.  Lack of β, β-carotene-9', 10'-oxygenase 2 leads to hepatic mitochondrial dysfunction and cellular oxidative stress in mice.

Authors:  Lei Wu; Xin Guo; Steven D Hartson; Mary Abby Davis; Hui He; Denis M Medeiros; Weiqun Wang; Stephen L Clarke; Edralin A Lucas; Brenda J Smith; Johannes von Lintig; Dingbo Lin
Journal:  Mol Nutr Food Res       Date:  2017-02-09       Impact factor: 5.914

3.  Effects of all-trans retinoic acid on angiotensin II-induced myocyte hypertrophy.

Authors:  Hao-Jie Wang; Yi-Chun Zhu; Tai Yao
Journal:  J Appl Physiol (1985)       Date:  2002-05

4.  Radiation Nephropathy in a Nonhuman Primate Model of Partial-body Irradiation with Minimal Bone Marrow Sparing-Part 1: Acute and Chronic Kidney Injury and the Influence of Neupogen.

Authors:  Eric P Cohen; Kim G Hankey; Ann M Farese; George A Parker; Jace W Jones; Maureen A Kane; Alexander Bennett; Thomas J MacVittie
Journal:  Health Phys       Date:  2019-03       Impact factor: 1.316

5.  Overexpression of collagen type III in injured myocardium prevents cardiac systolic dysfunction by changing the balance of collagen distribution.

Authors:  Ayako Uchinaka; Maho Yoshida; Kiyoka Tanaka; Yoshinosuke Hamada; Seiji Mori; Yoshitaka Maeno; Shigeru Miyagawa; Yoshiki Sawa; Kohzo Nagata; Hirofumi Yamamoto; Naomasa Kawaguchi
Journal:  J Thorac Cardiovasc Surg       Date:  2018-02-21       Impact factor: 5.209

6.  Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study.

Authors:  Anthony J Swerdlow; Craig D Higgins; Paul Smith; David Cunningham; Barry W Hancock; Alan Horwich; Peter J Hoskin; Andrew Lister; John A Radford; Ama Z S Rohatiner; David C Linch
Journal:  J Natl Cancer Inst       Date:  2007-02-07       Impact factor: 13.506

7.  Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy.

Authors:  J Cuzick; H Stewart; L Rutqvist; J Houghton; R Edwards; C Redmond; R Peto; M Baum; B Fisher; H Host
Journal:  J Clin Oncol       Date:  1994-03       Impact factor: 44.544

8.  Factors affecting late mortality from heart disease after treatment of Hodgkin's disease.

Authors:  S L Hancock; M A Tucker; R T Hoppe
Journal:  JAMA       Date:  1993-10-27       Impact factor: 56.272

Review 9.  Modulation of retinoid signaling: therapeutic opportunities in organ fibrosis and repair.

Authors:  Suya Wang; Jianshi Yu; Maureen A Kane; Alexander R Moise
Journal:  Pharmacol Ther       Date:  2019-10-16       Impact factor: 12.310

10.  The Effect of Radiation Dose and Variation in Neupogen® Initiation Schedule on the Mitigation of Myelosuppression during the Concomitant GI-ARS and H-ARS in a Nonhuman Primate Model of High-dose Exposure with Marrow Sparing.

Authors:  Thomas J MacVittie; Alexander W Bennett; Ann M Farese; Cheryl Taylor-Howell; Cassandra P Smith; Allison M Gibbs; Karl Prado; William Jackson
Journal:  Health Phys       Date:  2015-11       Impact factor: 2.922

View more
  2 in total

1.  Animal Models: A Non-human Primate and Rodent Animal Model Research Platform, Natural History, and Biomarkers to Predict Clinical Outcome.

Authors:  Thomas J MacVittie; Ann M Farese; Maureen A Kane
Journal:  Health Phys       Date:  2021-10-01       Impact factor: 2.922

2.  Role of cellular retinol-binding protein, type 1 and retinoid homeostasis in the adult mouse heart: A multi-omic approach.

Authors:  Stephanie Zalesak-Kravec; Weiliang Huang; Jace W Jones; Jianshi Yu; Jenna Alloush; Amy E Defnet; Alexander R Moise; Maureen A Kane
Journal:  FASEB J       Date:  2022-04       Impact factor: 5.834

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.